Untech announced a landmark strategic partnership with Elea, one of the leading pharmaceutical companies in Latin America, to co-develop and commercialize its innovative chronic wound therapy across the region.

Untech announced the publication of its latest scientific paper in Wiley’s Health Science Reports, presenting a novel perspective on chronic wound treatment.

Untech has been recognized in the Global Startup Heat Map as one of the top 5 wound care management startups worldwide, selected from a pool of 366 companies.

Untech was recognized as the Best Startup at the Korea–LAC Summit, a key platform connecting innovation ecosystems between Korea and Latin America.

Untech was awarded first place in the Health category at the Samsung Innova, recognizing the company’s breakthrough approach to chronic wound treatment.

Untech was selected to participate in Acelerar España, an initiative led by Insud Pharma to support high-potential healthcare and life sciences ventures worldwide.

Untech announced that Dr. Thomas Serena, one of the world’s leading experts in chronic wound care and treatment innovation, has joined its Advisory Board.

Untech participated in the Advanced Wound Care Summit, a leading event dedicated to innovation in chronic wound treatment.

Untech participated in EWMA Barcelona, one of the most important global conferences dedicated to chronic wound management.

Untech was selected as one of 20 global startups to join the Singularity University accelerator program, held at the NASA campus in San Francisco, focused on breakthrough innovation.